Trends in HIV seroprevalence among patients with sexually transmitted diseases in 17 European sentinel networks, 1990-1996

AIDS

Volumn 14, Issue 7, 2000, Pages 871-880

  Batter, Véronique ^a  

^a PASTEUR INSTITUTE OF BRUSSELS   (Belgium)

Author keywords

Europe; HIV; STD patients; Surveillance; Trends

Indexed keywords

ARTICLE; BISEXUALITY; EUROPE; FEMALE; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REGRESSION ANALYSIS; SEROPREVALENCE; SEXUALLY TRANSMITTED DISEASE;

ADULT; BISEXUALITY; EUROPE; FEMALE; HIV ANTIBODIES; HIV INFECTIONS; HIV SEROPREVALENCE; HIV-1; HOMOSEXUALITY, MALE; HUMANS; MALE; SENTINEL SURVEILLANCE; SEROEPIDEMIOLOGIC STUDIES; SEXUALLY TRANSMITTED DISEASES; SUBSTANCE ABUSE, INTRAVENOUS; TIME FACTORS;

EID: 0034077089     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200005050-00014     Document Type: Article

References (42)

1. 1. Onorato IM, Gwinn M, Dondero Jr TJ. Applications of data from the CDC Family of Surveys. Public Health Rep 1994;109: 204-211.
2. 2. European Centre for the Epidemiological Monitoring of AIDS. European HIV Prevalence Database. December 1996 update. Saint Maurice: European Centre for the Epidemiological Monitoring of AIDS; 1997.
3. 3. Hamers FF, Downs AM, Infuso A, Brunet JB. Diversity of the HIV/AIDS epidemic in Europe. AIDS 1998, 12 (suppl A): S63-S70.
4. 4. European Centre for the Epidemiological Monitoring of AIDS. HIV Testing and Individual Case Reporting in Europe. Saint-Maurice: European Centre for the Epidemiological Monitoring of AIDS; 1998.
5. 5. Suligoi B, Giuliani M, Binkin N. The national STD surveillance system in Italy: results of the first year of activity. STD Surveillance Working Group. Int J STD AIDS 1994, 5:93-100.
6. 6. PHLS Communicable Disease Surveillance Centre. Unlinked Anonymous HIV Seroprevalence Monitoring Programme England-Wales. Report from the Unlinked Anonymous HIV Surveys Steering Group. Data to the end of 1995. London: Department of Health/PHLS; 1996.
7. 7. Paget WJ, Zimmermann HP. Surveillance of sexually transmitted diseases in Switzerland, 1973-1994: evidence of declining trends in gonorrhoea and syphilis. Soz Praventivmed 1997, 42:30-36.
8. 8. Meyer L, Couturier E, Brossard Y, et al. Trends in HIV infection among sexually transmitted disease patients in Paris. AIDS 1996, 10:401-405.
9. 9. Fennema JS, Van Ameijden EJ, Coutinho RA, van Doornum GJ, Cairo I, Van den Hoek A. HIV surveillance among sexually transmitted disease clinic attenders in Amsterdam, 1991-1996. AIDS 1998, 12:931-938.
10. 10. Smith E, Worm AM, Jepsen LV, et al. Patterns and trends of sexual behavior, HIV testing, and HIV prevalence among all sexually transmitted disease clinic attenders in Denmark. Sex Transm Dis 1994, 21:97-102.
11. 11. Scott G, Goldberg D, Weir M, et al. Prevalence of HIV-1 infection among heterosexual men and women attending genitourinary clinics in Scotland: unlinked anonymous testing. BMJ 1997, 315:1281-1282.
12. 12. Wasserheit JN. Epidemiology synergy. Interrelationships between human immunodeficiency virus infection and other sexually transmitted diseases. Sex Transm Dis 1992, 19:61-77.
13. 13. Cannon RO, Schmid GP, Moore PS, Pappaioannou M. Human immunodeficiency virus (HIV) seroprevalence in persons attending STD clinics in the United States, 1985-87. Sex Transm Dis 1989, 16:184-189.
14. 14. Cazein F, Hamers FF, Brunet JB. HIV prevalence in pregnant women in Europe: differences in assessment methods and prevalence levels across countries. J Acquir Immune Def Syndr Human Retroviral 1998, 19:269-305.
15. 15. Hamers FF, Batter V, Downs AM, Alix J, Cazein F, Brunet JB. The HIV epidemic associated with injecting drug use in Europe: geographic and time trends. AIDS 1997, 11:1365-1374.
16. 16. Pappaioanou M, Dondero Jr TJ, Petersen LR, et al. The family of HIV seroprevalence surveys: objectives, methods, and uses of sentinel surveillance for HIV in the United States. Public Health Rep 1990, 105:113-119.
17. 17. Weinstock HS, Sidhu J, Gwinn M, Karon J, Petersen LR. Trends in HIV seroprevalence among persons attending sexually transmitted disease clinics in the United States, 1988-1992. J Acquir Immune Defic Syndr Hum Retrovirol 1995, 9:514-522.
18. 18. The European Study Group. European Community Concerted Action on HIV seroprevalence among sexually transmitted disease patients in 18 European sentinel networks. AIDS 1993, 7:393-400.
19. 19. Stroobant A. Monitoring HIV seroprevalence in a sentinel population constituted by STD patients. In: AIDS Research at EC Level. Edited by Baert A-E, et al. Brussels: IOS Press;1995: 107-134.
20. 20. Van der Heyden, Batter V, Sasse A, Stroobant A, European Study Group. European Networks for the Surveillance of HIV Infections in Sentinel Populations of STD Patients. A Concerted Action Project of the European Communities (DC XII), Brussels: Final results 1990-1996. Brussels: Scientific Institute for Public Health - Louis Pasteur; 1997.
21. 21. Goldberg D, Davis B, Allardice G, McMenamin J, Codere G. Monitoring the spread of HIV and AIDS in Scotland 1983-1994. Scot Med J 1996, 41:131-138.
22. 22. Fennema JS, Van Ameijden EJ, Coutinho RA, van den Hoek AA. HIV, sexually transmitted diseases and gynaecologic disorders in women: increased risk for genital herpes and warts among HIV-infected prostitutes in Amsterdam. AIDS 1995, 9:1071-1078.
23. 23. Renton AM, Whitaker L. Using STD occurrence to monitor AIDS prevention. Soc Sci Med 1994, 38:1153-1165.
24. 24. Batter V, Van der Heyden J, Sasse A, Stroobant A, and the European Study Group. European Networks for the Surveillance of HIV Infections in Sentinel Populations of STD Patients. A Concerted Action Project of the European Communities (DGXII), Brussels: Evaluation report. Brussels: Scientific Institute for Public Health - Louis Pasteur; 1997.
25. 25. van Griensven GJ, de Vroome EM, Goudsmit J, Coutinho RA. Changes in sexual behaviour and the fall in incidence of HIV infection among homosexual men. BMJ 1989, 298:218-221.
26. 26. Mertens TE, Low Beer D. HIV and AIDS: where is the epidemic going? Bull WHO 1996, 74:121-129.
27. 27. van den Hoek JA, van Griensven GJ, Keet IP, Coutinho RA. HIV incidence in a cohort of homosexual men and a cohort of injecting drug users in Amsterdam, 1985-1995 [in Dutch]. Ned Tijdschr Geneeskd 1996, 140:1692-1695.
28. 28. van Haastrecht HJ, Bindels PJ, van den Hoek AA, Coutinho RA. Estimating the size of the HIV epidemic among injecting drug users in Amsterdam. Eur J Epidemiol 1997, 13:261-265.
29. 29. Romano N, Vitale F, Alesi DR, et al. The changing patterns of human immunodeficiency virus type 1 infection in intravenous drug users. Results of a six-year seroprevalence study in Palermo, Italy. Am J Epidemiol 1998, 135:1189-1196.
30. 30. Stimson GV, Hunter GM, Donoghoe MC, Rhodes T, Parry JV, Chalmers CP. HIV-1 prevalence in community-wide samples of injecting drug users in London, 1990-1993. AIDS 1996, 10:657-666.
31. 31. Ingram M. Russia fears rapid increase in HIV infection [news]. BMJ 1997, 314:1783.
32. 32. Maly M, Bruckova M. Lessons learned in HIV/AIDS surveillance system in the Czech Republic. Meeting on the Surveillance of HIV Infection in Europe. St. Maurice, February 1998.
33. 33. Nicoll A, McGarrigle C, Brady AR, et al. Epidemiology and detection of HIV-1 among pregnant women in the United Kingdom: results from national surveillance 1988-96. BMJ 1998, 316:253-257.
34. 34. Giuliani M, Suligoi B. Increasing trend in HIV-1 prevalence among STD heterosexual females: data from the STD surveillance Working Group. X International Conference on AIDS. Yokohama, August 1994 [abstract PC0008].
35. 35. Sasse A, Van der heyden J, Stroobant A. Epidemiologie du SIDA et de l'infection à VIH en Belgique. Situation au 31 décembre 1996. Brussels: Scientific Institute for Public Health - Louis Pasteur; 1997.
36. 36. Downs AM, Heisterkamp SH, Brunet JB, Hamers FF. Reconstruction and prediction of the HIV/AIDS epidemic among adults in the European Union and in the low prevalence countries of central and eastern Europe. AIDS 1997, 11:649-662.
37. 37. Cronberg S. The rise and fall of sexually transmitted diseases in Sweden. Genitourin Med 1993, 69:184-186.
38. 38. Meyer L, Goulet V, Massari V, Lepoutre Toulemon A. Surveillance of sexually transmitted diseases in France: recent trends and incidence. Genitourin Med 1994, 70:15-21.
39. 39. Postema EJ, Willems PW, de Ridder MA, van der Meijden WI. Comparison of patients refusing with patients accepting unlinked anonymous HIV testing in an outpatient STD department in The Netherlands. Int J STD AIDS 1997, 8:368-372.
40. 40. Paget WJ, Zwahlen M, Eichmann AR, the Swiss Network of Dermatovenereology Policlinics. Voluntary confidential HIV testing of STD patients in Switzerland, 1990-5: HIV test refusers cause different biases on HIV prevalences in heterosexuals and homo/bisexuals. Genitourin Med 1997, 73:444-447.
41. 41. Noone A, Mortimer JY. Voluntary testing to measure HIV prevalence in sexually transmitted disease clinics. Commun Dis Rep CDR Rev 1992, 2:R21-R24.
42. 42. European Centre for the Epidemiological Monitoring of AIDS. Surveillance systems for HIV infection in European countries. HIV/AIDS Surv Quart Rep 1994, 42:36-46.